U.K. Biotech, Oxford Immune Algorithmics (OIA) Presents Algocyte at MWC /4YFN Barcelona in the Great Britain & Northern Ireland Pavilion @algocyte (Twitter)

Share this

Oxford Immune Algorithmics (OIA), the creators of Algocyte , and rapid at-home testing for AI-driven immune health monitoring, and AI-driven solution that thinks like a scientist, announced they are exhibiting at MWC/4YFN in Barcelona, February 28th – March 3rd. The award-winning UK-based biotech spin-off from Oxford University says it is proud to be included the Great Britain and Northern Ireland Pavilion.

MWC/4YFN is the world’s most significant connectivity industry event and is attended by global mobile operators, device manufacturers, technology providers, vendors, and content owners. World-leading companies, mobile and tech influencers, and health tech pioneers will engage in thought-leadership discussions on the progression and future of connectivity. Oxford Immune Algorithmics will contribute as AI and immune health monitoring leaders and showcase its AI-driven product Algocyte.

Algocyte will radically change global healthcare, moving it away from its current reliance on population-wide reference values towards a patient-centric approach focused on personalised immune system monitoring. OIA’s AI-driven solution, Algocyte, monitors the immune system using responsible A.I. that reasons like a human medical expert, and is able to explain its decisions, empowering both patients and clinicians.

Oxford Immune Algorithmics (OIA) is an award-winning AI company, incubated by the University of Oxford, that specialises in rapid at-home testing for immune health monitoring.  It uses the best of human and computational intelligence to deliver precise and individualised healthcare to everyone and rid the world of preventable diseases.

Sign up to receive more information